Avicenna.AI
About Avicenna.AI
Avicenna.AI is a medical AI company specializing in developing advanced AI-based solutions for radiology, primarily focused on emergency imaging and the detection of incidental findings from CT medical images. Their comprehensive suite of tools, known as CINA applications, leverages deep learning and machine learning technologies to identify, detect, and quantify life-threatening pathologies. These solutions are designed to seamlessly integrate into existing clinical workflows, automatically triggering and reporting algorithm results to radiologists, thereby accelerating therapeutic decision-making and improving patient outcomes.
For physicians, Avicenna.AI’s portfolio addresses critical areas such as neurovascular emergencies (e.g., CINA-ICH for intracranial hemorrhage, CINA-LVO for large vessel occlusion, and CINA-ASPECTS for stroke severity quantification), and thoraco-abdominal pathologies (e.g., CINA-PE for pulmonary embolism and CINA-AD for aortic dissection). They also offer solutions for incidental findings like CINA-iPE for unsuspected pulmonary embolism, and spine-focused tools such as CINA-CSpine for cervical spine fractures and CINA-VCF Quantix for vertebral compression fractures. The company emphasizes augmenting the physician’s workflow by providing rapid, reliable insights and prioritizing urgent cases, ultimately enhancing diagnostic confidence and efficiency without replacing human interpretation.
Focus Areas
Business Intelligence
| Key Investors | Innovacom, CEMAG Invest, EIT Community Booster, Turenne Groupe, Incubateur Impulse |
| Partnerships | Ferrum Health, ConcertAI's TeraRecon, deepc, Bracco Imaging, Viz.ai, RMS Medical Devices, TIM, Canon Medical |
| Technology | Deep learning, machine learning, AVI Platform (integrates with PACS and RIS via DICOM, HL7, FHIR, cloud-native architecture implied for seamless integration and data processing) |
| FDA Clearances | 8 cleared products (estimated) |
What Physicians Need to Know
Avicenna.AI's solutions are designed to act as a 'second pair of eyes,' providing fast, reliable insights that accelerate disease detection and improve therapeutic decision-making. By automating repetitive tasks and prioritizing urgent cases, the AI tools enhance radiology workflow, reduce interpretation time, and increase diagnostic confidence, allowing physicians to focus on complex cases and optimize patient management. The focus is on augmenting human decision-making and improving patient outcomes without disrupting existing clinical practices.
Avicenna.AI's solutions, including their AVI Platform, are engineered for seamless integration into existing radiologists' clinical workflows, directly with PACS and RIS platforms. The integration is 'invisible' to end-users, requiring no additional viewers, worklists, training, or changes to current workflows, and results appear as additional images with alerts. The platform supports global standards such as DICOM, HL7, and FHIR, ensuring compatibility and enabling a one-time integration for access to all applications. They also integrate with other platforms like Viz.ai One.
Reviews & Opinions
Videos
News, demos, and interviews about Avicenna.AI.
Videos load interactively. If none appear, search YouTube for Avicenna.AI →
Press & Coverage
Frequently Asked Questions
Related Companies
Precision Medical Ventures, Inc. Dba Revealdx (RevealDx) is a Seattle-based healthcare AI company focused on dramatically improving lung cancer outcomes through non-invasive diagnosis. They develop advanced, radiomics and AI-enabled, lung cancer decision support software. Their flagship product, RevealAI-Lung, is a Computer-Assisted Diagnostic (CADx) software that analyzes patient lung computed tomography (CT) images to provide information […]
SafeBeat Rx is a healthcare AI company focused on transforming cardiac care by expanding access to remote patient monitoring (RPM), continuous telemetry, event monitoring, and software-enabled remote therapeutic monitoring (RTM). The company’s core offering is an integrated technology that utilizes automated artificial intelligence-based software to analyze electrocardiogram (ECG) data. This technology is designed to replace […]
Measure Labs, Inc., operating as PreemptiveAI, Inc., is a healthcare AI company focused on transforming healthcare from reactive disease management to proactive risk identification and prevention. The company has developed a “revolutionary” foundation model, a large-scale machine learning model, that interprets biomedical signals from smartphones and wearable devices to predict health outcomes in real-time. This […]
EarliPoint Health, formerly EarliTec Diagnostics, is a healthcare AI company dedicated to transforming autism care through innovative, FDA-cleared eye-tracking technology. The company’s core product, the EarliPoint System, is a medical device designed to aid qualified clinicians in the diagnosis and assessment of Autism Spectrum Disorder (ASD) in children aged 16 months through 95 months (7 […]
Onera B.V., operating as Onera Health, is a Dutch med-tech company that is transforming sleep diagnostics and monitoring with its innovative, self-applied, no-wire polysomnography (PSG) solution. [12, 19] Founded as a spin-off from the imec research center, a leader in nanoelectronics and digital technologies, Onera aims to make clinical-grade sleep studies broadly accessible, convenient, and […]
Digestaid – Artificial Intelligence Development SA is a healthcare AI company focused on developing advanced deep learning solutions for the detection of digestive lesions. The company aims to revolutionize gastrointestinal practice by applying AI technologies across digestive and pancreatobiliary tracts, as well as functional tests. Their solutions are designed to overcome diagnostic limitations of current […]